Literature DB >> 30975233

Malignant otitis externa, an increasing burden in the twenty-first century: review of cases in a UK teaching hospital, with a proposed algorithm for diagnosis and management.

K H Hutson1, G J Watson2.   

Abstract

BACKGROUND: Malignant otitis externa is a potentially fatal infection of the skull base. With an ageing population and increasing prevalence of diabetes, the incidence of malignant otitis externa in the British population is rising. To date, there remain no accepted diagnostic criteria, few prognostic indicators and no consensus treatment pathways.
METHOD: A prospective case series was conducted at a tertiary referral teaching hospital.
RESULTS: A cohort of susceptible individuals predominates (elderly, male, with immunosuppression and diabetes), with 25 per cent reporting a preceding incident. Otorrhoea, otalgia and canal granulation were the commonest presenting features, alongside positive pseudomonas cultures. No clear markers for predicating disease severity were isolated; however, a high initial haemoglobin A1c level demonstrated a significant moderately positive correlation with length of treatment.
CONCLUSION: A treatment pathway designed to provide a standardised approach to investigation and treatment is proposed, which aims to increase earlier diagnosis, streamline care and facilitate the development of best practice.

Entities:  

Keywords:  Diabetes Mellitus; Otitis Externa; Pseudomonas; Skull Base

Mesh:

Year:  2019        PMID: 30975233     DOI: 10.1017/S0022215119000604

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Malignant Otitis Externa: Causes for Various Treatment Responses.

Authors:  Nenad Arsovic; Nemanja Radivojevic; Snezana Jesic; Snezana Babac; Ljiljana Cvorovic; Zoran Dudvarski
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

2.  A Different Era for Malignant Otitis Externa: The Non-Diabetic and Non-Immunocompromised Patients.

Authors:  Giorgos Sideris; John Latzonis; Caroline Avgeri; Vangelis Malamas; Alexander Delides; Thomas Nikolopoulos
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.